Literature DB >> 9143508

Localization of the human Ror1 gene (NTRKR1) to chromosome 1p31-p32 by fluorescence in situ hybridization and somatic cell hybrid analysis.

U R Reddy1, S Phatak, C Allen, L M Nycum, E P Sulman, P S White, J A Biegel.   

Abstract

Ror1 is an orphan cell surface receptor with strong homology to the tyrosine kinase domain of growth factor receptors, in particular the Trk family. Southern blot analysis of genomic DNA from somatic cell hybrids revealed that Ror1 is located on chromosome 1. We have mapped the Ror1 gene to chromosome 1p12-p32 using PCR on a somatic cell hybrid panel that subdivides chromosome 1p. We have further localized the gene to chromosome 1p31-p32 by fluorescence in situ hybridization using a PAC clone that contains the Ror1 gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143508     DOI: 10.1006/geno.1997.4653

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  7 in total

Review 1.  Robinow syndrome.

Authors:  M A Patton; A R Afzal
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

2.  Expression of ROR1 in patients with renal cancer--a potential diagnostic marker.

Authors:  Hodjattallah Rabbani; Mahyar Ostadkarampour; Amir Hossein Danesh Manesh; Abbas Basiri; Mahmood Jeddi-Tehrani; Flora Forouzesh
Journal:  Iran Biomed J       Date:  2010-07

Review 3.  MicroRNA dysregulation and multi-targeted therapy for cancer treatment.

Authors:  Veronica Balatti; Carlo M Croce
Journal:  Adv Biol Regul       Date:  2019-10-13

4.  Monoclonal Antibody Against ROR1 Induces Apoptosis in Human Bladder Carcinoma Cells.

Authors:  Ali-Ahmad Bayat; Niloufar Sadeghi; Ramina Fatemi; Mohammad Reza Nowroozi; Solmaz Ohadian Moghadam; Mohadeseh Borzuee; Amin Radmanesh; Mahmood Khodadoost; Ali Reza Sarrafzadeh; Omid Zarei; Hodjattallah Rabbani
Journal:  Avicenna J Med Biotechnol       Date:  2020 Jul-Sep

Review 5.  Ror2 as a therapeutic target in cancer.

Authors:  Zufan Debebe; W Kimryn Rathmell
Journal:  Pharmacol Ther       Date:  2015-01-19       Impact factor: 13.400

6.  ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy.

Authors:  Guilly Rebagay; Su Yan; Cheng Liu; Nai-Kong Cheung
Journal:  Front Oncol       Date:  2012-04-18       Impact factor: 6.244

7.  Construction and Stable Expression of a Truncated Human Receptor Tyrosine Kinase Ror1 (Ror1-ECD).

Authors:  Flora Forouzesh; Samira Shakeri Tabarian; Shaghayegh Emami; Mahmood-Jeddi Tehrani; Reza Hadavi; Hodjattallah Rabbani
Journal:  Avicenna J Med Biotechnol       Date:  2012-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.